Advertisement

Neuroprotective activity of leukemia inhibitory factor is relayed through myeloid zinc finger-1 in a rat model of stroke

  • Stephanie M. Davis
  • Lisa A. Collier
  • Elspeth A. Foran
  • Christopher C. Leonardo
  • Craig T. AjmoJr
  • Keith R. Pennypacker
Original Article

Abstract

The aim of this study was to determine whether leukemia inhibitory factor (LIF) exerts its neuroprotective effects through signal transduction of the transcription factor myeloid zinc finger-1 (MZF-1). According to the hypothesis of this study, MZF-1 mediates LIF-induced neuroprotective signaling during ELVO through increased expression and transcriptional activity. To determine the in vivo role of MZF-1 in LIF-induced neuroprotection, we used Genomatix software was used to MZF-1 sites in the promoter region of the rat superoxide dismutase 3 (SOD3) gene. Stroke was induced via middle cerebral artery occlusion, and animals were administered PBS or 125 μg/kg LIF at 6, 24, and 48 h after the injury. MZF-1 binding activity was measured using electrophoretic mobility shift assay (EMSA) and its expression/localization were determined using western blot and immunohistochemical analysis. To determine whether MZF-1 relays LIF-induced neuroprotection in vitro, primary cultured neurons were subjected to oxygen-glucose deprivation (OGD) after treatment with PBS or LIF. MZF-1 expression was measured in vitro using real time PCR and immunohistochemical staining. Transfection with siRNA was used to determine whether LIF protected cultured neurons against OGD after silencing MZF-1 expression. Four MZF-1 binding sites were identified by Genomatix, and EMSA confirmed in vivo binding activity in brain after MCAO. LIF significantly increased MZF-1 protein levels compared to PBS treatment at 72 h post-MCAO. In vivo nuclear localization of MZF-1 as well as co-localization of SOD3 and MZF-1 was observed in the cortical neurons of LIF-treated rats. Primary cultured neurons treated with LIF had significantly higher levels of MZF-1 mRNA and protein after LIF treatment compared to neurons treated with PBS. Finally, knockdown MZF-1 using siRNA counteracted the neuroprotective effects of LIF in vitro. These data demonstrate that LIF-mediated neuroprotection is dependent upon MZF-1 activity. Furthermore, these findings identify a novel neuroprotective pathway that employs MZF-1, a transcription factor associated with hematopoietic gene expression.

Keywords

Transcription factors Ischemia Stroke Antioxidants Cytokines Neurosurvival 

Abbreviations

ELVO

emergent large vessel occlusion

EVT

endovascular thrombectomy

LDH

lactate dehydrogenase

LIF

leukemia inhibitory factor

MCAO

middle cerebral artery occlusion

MZF-1

myeloid zinc finger-1

NeuN

neuronal nuclear antigen

SOD3

superoxide dismutase 3

TF

transcription factor

tPA

tissue plasminogen activator

Notes

Acknowledgements

The authors would like to acknowledge Dr. Jerome Breslin at the University of South Florida for the use of his laboratory’s Nucleofector™ device as well as Dr. Chris Katnik for his assistance in the isolation of primary rat neurons.

Funding

Funding for the experiments detailed in this paper was provided by the National Institute for Neurological Disorders and Stroke [Grants: 1R21NS078517–01, 1R56NS091146–01, and 1R01NS091146-01].

Compliance with ethical standards

Conflict of interest

None

References

  1. Ajmo CT Jr, Vernon DO, Collier L, Pennypacker KR, Cuevas J (2006) Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 3(2):89–98PubMedCrossRefGoogle Scholar
  2. Azari MF, Galle A, Lopes EC, Kurek J, Cheema SS (2001) Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis. Brain Res 922(1):144–147PubMedCrossRefGoogle Scholar
  3. Barber PA, Demchuk AM, Zhang J, Buchan AM, A. S. Group (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355(9216):1670–1674PubMedCrossRefGoogle Scholar
  4. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA, Emery B, Turnley AM, Petratos S, Ernst M, Bartlett PF, Kilpatrick TJ (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8(6):613–619PubMedCrossRefGoogle Scholar
  5. Davis SM, Collier LA, Leonardo CC, Seifert HA, Ajmo CT, Pennypacker KR (2017) Leukemia inhibitory factor protects neurons from ischemic damage via upregulation of superoxide dismutase 3. Mol Neurobiol 54(1):608–622PubMedCrossRefGoogle Scholar
  6. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11(5):1475–1489PubMedPubMedCentralCrossRefGoogle Scholar
  7. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391–397CrossRefGoogle Scholar
  8. Fukui S, Ookawara T, Nawashiro H, Suzuki K, Shima K (2002) Post-ischemic transcriptional and translational responses of EC-SOD in mouse brain and serum. Free Radic Biol Med 32(3):289–298PubMedCrossRefGoogle Scholar
  9. Gärtner A, Collin L, Lalli G (2006) Nucleofection of primary neurons. Methods Enzymol 406:374–388PubMedCrossRefGoogle Scholar
  10. Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CBLM, van der Lugt A, de Miquel MA, Donnan GA, Roos YBWEM, Bonafe A, Jahan R, Diener H-C, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BCV, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723–1731PubMedCrossRefGoogle Scholar
  11. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329PubMedCrossRefGoogle Scholar
  12. Hall AA, Guyer AG, Leonardo CC, Ajmo CT Jr, Collier LA, Willing AE, Pennypacker KR (2009) Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death. J Neurosci Res 87(2):333–341PubMedPubMedCentralCrossRefGoogle Scholar
  13. Hastrup S, Damgaard D, Johnsen SP, Andersen G (2016) Prehospital acute stroke severity scale to predict large artery occlusion: design and comparison with other scales. Stroke 47(7):1772–1776PubMedCrossRefGoogle Scholar
  14. Hendriks JJ, Slaets H, Carmans S, de Vries HE, Dijkstra CD, Stinissen P, Hellings N (2008) Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 204(1–2):52–57PubMedCrossRefGoogle Scholar
  15. Hromas R, Collins SJ, Hickstein D, Raskind W, Deaven LL, O'Hara P, Hagen FS, Kaushansky K (1991) A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem 266(22):14183–14187PubMedGoogle Scholar
  16. Hromas R, Boswell S, Shen RN, Burgess G, Davidson A, Cornetta K, Sutton J, Robertson K (1996a) Forced over-expression of the myeloid zinc finger gene MZF-1 inhibits apoptosis and promotes oncogenesis in interleukin-3-dependent FDCP.1 cells. Leukemia 10(6):1049–1050PubMedGoogle Scholar
  17. Hromas R, Davis B, Rauscher F III, Klemsz M, Tenen D, Hoffman S, Xu D, Morris J (1996b) Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. Molecular Aspects of Myeloid Stem Cell Development. Springer, New York, pp 159–164Google Scholar
  18. Hui P, Guo X, Bradford PG (1995) Isolation and functional characterization of the human gene encoding the myeloid zinc finger protein MZF-1. Biochem 34(50):16493–16502CrossRefGoogle Scholar
  19. Ip NY, Nye SH, Boulton TG, Davis SM, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD (1992) CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69(7):1121–1132PubMedCrossRefGoogle Scholar
  20. Katnik C, Guerrero WR, Pennypacker KR, Herrera Y, Cuevas J (2006) Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. J Pharmacol Exp Ther 319(3):1355–1365PubMedCrossRefGoogle Scholar
  21. Kim JH, Bogner PN, Baek SH, Ramnath N, Liang P, Kim HR, Andrews C, Park YM (2008) Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target. Clin Cancer Res 14(8):2326–2333PubMedCrossRefGoogle Scholar
  22. Leonardo CC, Pennypacker KR (2011) The splenic response to ischemic stroke: what have we learned from rodent models? Transl Stroke Res 2:328–338PubMedCrossRefGoogle Scholar
  23. Leonardo CC, Hall AA, Collier LA, Ajmo CTJ, Willing AE, Pennypacker KR (2010) Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD-11b-expressing isolectin-binding proinflammatory cells after middle cerebral artery occlusion. J Neurosci Res 88(6):1213–1222PubMedPubMedCentralGoogle Scholar
  24. Luo X, Zhang X, Shao W, Yin Y, Zhou J (2009) Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures. J Neurochem 108(4):952–961PubMedCrossRefGoogle Scholar
  25. Madsen TE, Melluzzo S, Wira CR, Magdon-Ismail Z, Day D, Gropen T, Investigators NCC (2017) Minorities, women, and stroke belters left behind in t-PA use despite quality improvement efforts. Stroke 48(suppl_1):A116–A116Google Scholar
  26. Marriott MP, Emery B, Cate HS, Binder MD, Kemper D, Wu Q, Kolbe S, Gordon IR, Wang H, Egan G, Murray S, Butzkueven H, Kilpatrick TJ (2008) Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 56(6):686–698PubMedCrossRefGoogle Scholar
  27. McMeekin P, White P, James MA, Price CI, Flynn D, Ford GA (2017) Estimating the number of UK stroke patients eligible for endovascular thrombectomy. Eur Stroke J 2(4):319–326PubMedPubMedCentralCrossRefGoogle Scholar
  28. Mizusawa H, Ishii T, Bannai S (2000) Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci Lett 283(1):57–60PubMedCrossRefGoogle Scholar
  29. Moeenrezakhanlou A, Shephard L, Lam L, Reiner NE (2008) Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J Leukoc Biol 84(2):519–528PubMedCrossRefGoogle Scholar
  30. Morris J, Davis B, Klemsz M, Xu D, Tenen D, Hromas R (1995) The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. Blood 86(10):3640–3647PubMedGoogle Scholar
  31. Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T, Yamauchi-Takihara K (1998) Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J Biol Chem 273(16):9703–9710PubMedCrossRefGoogle Scholar
  32. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B (2018) 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46–e99PubMedCrossRefGoogle Scholar
  33. Rousseeuw PJ, Hubert M (2011) Robust statistics for outlier detection. Wiley Interdiscip Rev Data Min Knowl Discov 1(1):73–79CrossRefGoogle Scholar
  34. Rowe DD, Leonardo CC, Hall AA, Shahaduzzaman MD, Collier LA, Willing AE, Pennypacker KR (2010) Cord blood administration induces oligodendrocyte survival through alterations in gene expression. Brain Res 1366:172–188PubMedPubMedCentralCrossRefGoogle Scholar
  35. Rowe DD, Leonardo CC, Recio JA, Collier LA, Willing AE, Pennypacker KR (2012) Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction. J Biol Chem 287(6):4177–4187PubMedCrossRefGoogle Scholar
  36. Rowe DR, Collier LA, Seifert HA, Chapman CB, Leonardo CC, Willing AE, Pennypacker KR (2014) Leukemia inhibitory factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia. Eur J Neurosci 40:3111–3119PubMedPubMedCentralCrossRefGoogle Scholar
  37. Schabitz WR, Kruger C, Pitzer C, Weber D, Laage R, Gassler N, Aronowski J, Mier W, Kirsch F, Dittgen T, Bach A, Sommer C, Schneider A (2007) A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 28(1):29–43PubMedCrossRefGoogle Scholar
  38. Seifert HA, Leonardo CC, Hall AA, Rowe DD, Collier LA, Benkovic SA, Willing AE, Pennypacker KR (2012) The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling. Metab Brain Dis 27(2):131–141PubMedPubMedCentralCrossRefGoogle Scholar
  39. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S (2008) Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 39(4):1205–1212PubMedCrossRefGoogle Scholar
  40. Strålin P, Karlsson K, Johansson BO, Marklund SL (1995) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15(11):2032–2036PubMedCrossRefGoogle Scholar
  41. Suzuki S, Yamashita T, Tanaka K, Hattori H, Sawamoto K, Okano H, Suzuki N (2005) Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats. J Cereb Blood Flow Metab 25(6):685–693PubMedCrossRefGoogle Scholar
  42. Takahashi K, Hayashi N, Kaminogawa S, Ra C (2006) Molecular mechanisms for transcriptional regulation of human high-affinity IgE receptor beta-chain gene induced by GM-CSF. J Immunol 177(7):4605–4611PubMedCrossRefGoogle Scholar
  43. Talwalkar A, Uddin, S, N. C. f. H. Statistics (2015) Trends in Emergency Department Visits for Ischemic Stroke and Transient Ischemic Attack: United States, 201–2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health StatisticsGoogle Scholar
  44. Tsai SJ, Hwang JM, Hsieh SC, Ying TH, Hsieh YH (2012) Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells. Biochem Biophys Res Commun 425(2):462–467PubMedCrossRefGoogle Scholar
  45. Zelko I, Folz R (2003) Myeloid zinc finger (MZF)-like, Kruppel-like and Ets families of transcription factors determine the cell-specific expression of mouse extracellular superoxide dismutase. Biochem J 369:375–386PubMedPubMedCentralCrossRefGoogle Scholar
  46. Zelko IN, Folz RJ (2004) Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase. Free Radic Biol Med 37(8):1256–1271PubMedCrossRefGoogle Scholar
  47. Zelko IN, Mariani TJ, Folz RJ (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33(3):337–349PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Stephanie M. Davis
    • 1
  • Lisa A. Collier
    • 1
  • Elspeth A. Foran
    • 2
  • Christopher C. Leonardo
    • 3
  • Craig T. AjmoJr
    • 3
  • Keith R. Pennypacker
    • 1
    • 4
  1. 1.Department of NeurologyUniversity of KentuckyLexingtonUSA
  2. 2.Department of Molecular MedicineUniversity of South FloridaTampaUSA
  3. 3.Department of Molecular Pharmacology and PhysiologyUniversity of South FloridaTampaUSA
  4. 4.Department of NeuroscienceUniversity of KentuckyLexingtonUSA

Personalised recommendations